Literature DB >> 14596023

[Etiopathogenesis of inflammatory bowel diseases].

László Lakatos1, Péter László Lakatos.   

Abstract

The pathogenesis of IBD is only partly understood; various environmental and host (e.g. genetic-, epithelial-, immune and non-immune) factors are involved. It is a multifactorial polygenic disease with probable genetic heterogeneity, some genes are associated with IBD itself, while others increase the risk of ulcerative colitis (UC) or Crohn's disease (CD) or are associated with disease location and/or behaviour. The role of environmental factors, in particular, enteric antigens, smoking and non-steroid anti-inflammatory drug use has been well established. However uptil now no proof of a role of any unique pathogenic bacteria or special dietary and/or psychosocial factor has been identified. In this hypothesis, the disease may develop in a genetically predisposed host as a consequence of disregulated immune response to environmental, in particular, enteric antigens, resulting in a continuous immune-mediated inflammation (in CD predominantly Th-1, in UC a modified Th-2 mechanisms are involved) and not in tolerance. As a consequence, the permeability of mucosa and the antigen challenge increases, in contrast, the disregulated immune response is unable to downregulate the inflammatory process. This will result in a continuous inflammation and tissue damage. The pathogenesis of CD is thought to be mainly an antigen driven, T-lymphocyte dependent process, while in UC the role of epithelial factors and activated granulocytes are essential.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14596023

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  9 in total

Review 1.  Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

Authors:  L Lakatos; P L Lakatos
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

2.  Heat-shock protein 70-2 BB genotype is associated with reduced risks of the steroid-dependent and refractory phenotypes of ulcerative colitis.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masaaki Okubo; Takamitsu Ishizuka; Tomohiko Kawamura; Hiromi Yamashita; Masakatsu Nakamura; Yoshihito Nakagawa; Mitsuo Nagasaka; Tomiyasu Arisawa; Naoki Ohmiya; Ichiro Hirata
Journal:  Biomed Rep       Date:  2014-05-21

3.  Telomere length in non-neoplastic colonic mucosa in ulcerative colitis (UC) and its relationship to the severe clinical phenotypes.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masaaki Okubo; Tomohiko Kawamura; Kazuya Sumi; Takamitsu Ishizuka; Masakatsu Nakamura; Mitsuo Nagasaka; Yoshihito Nakagawa; Naoki Ohmiya; Tomiyasu Arisawa; Ichiro Hirata
Journal:  Clin Exp Med       Date:  2014-06-13       Impact factor: 3.984

4.  Association study of common genetic variants in pre-microRNAs in patients with ulcerative colitis.

Authors:  Masaaki Okubo; Tomomitsu Tahara; Tomoyuki Shibata; Hiromi Yamashita; Masakatsu Nakamura; Daisuke Yoshioka; Joh Yonemura; Yoshio Kamiya; Takamitsu Ishizuka; Yoshihito Nakagawa; Mitsuo Nagasaka; Masami Iwata; Hideto Yamada; Ichiro Hirata; Tomiyasu Arisawa
Journal:  J Clin Immunol       Date:  2010-09-17       Impact factor: 8.317

Review 5.  Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors:  Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

6.  Fusobacterium detected in colonic biopsy and clinicopathological features of ulcerative colitis in Japan.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Tomohiko Kawamura; Masaaki Okubo; Yuichiro Ichikawa; Kazuya Sumi; Masahiro Miyata; Takamitsu Ishizuka; Masakatsu Nakamura; Mitsuo Nagasaka; Yoshihito Nakagawa; Naoki Ohmiya; Tomiyasu Arisawa; Ichiro Hirata
Journal:  Dig Dis Sci       Date:  2014-08-08       Impact factor: 3.199

7.  Effect of RANTES gene promoter genotypes in patients with ulcerative colitis.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masaaki Okubo; Takamitsu Ishizuka; Tomohiko Kawamura; Hiromi Yamashita; Masakatsu Nakamura; Yoshihito Nakagawa; Mitsuo Nagasaka; Tomiyasu Arisawa; Naoki Ohmiya; Ichiro Hirata
Journal:  Biomed Rep       Date:  2014-05-21

8.  DNA methylation status of epithelial-mesenchymal transition (EMT)--related genes is associated with severe clinical phenotypes in ulcerative colitis (UC).

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masaaki Okubo; Takamitsu Ishizuka; Masakatsu Nakamura; Mitsuo Nagasaka; Yoshihito Nakagawa; Naoki Ohmiya; Tomiyasu Arisawa; Ichiro Hirata
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

Review 9.  Association of miRNA-146a rs2910164 and miRNA-196 rs11614913 polymorphisms in patients with ulcerative colitis: A meta-analysis and review.

Authors:  Zhongyi Li; Yao Wang; Yi Zhu
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.